MEI TSAN LI: Open Payments
NPI 1043880685 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$574 in 20 payments from 10 companies in 2025. Trend: 2023 $392 · 2024 $370 · 2025 $574
Food & beverage: $574
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $134 |
| GlaxoSmithKline, LLC. | 4 | $103 |
| Astellas Pharma US Inc | 3 | $95 |
| SOBI, INC | 2 | $61 |
| Incyte Corporation | 2 | $50 |
| ABBVIE INC. | 1 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Rigel Pharmaceuticals, Inc. | 1 | $27 |
| Syndax Pharmaceuticals, Inc. | 1 | $27 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
Products named: CALQUENCE, OJJAARA, Cresemba, Vonjo, JAKAFI, EPKINLY, Xospata, ICLUSIG.
Industry payments across TX — which companies pay providers there.
